Pricing Log in Create free account

Bright Minds Biosciences Inc. (DRUG) vs VectivBio Holding AG (VECT)

Bright Minds Biosciences Inc. and VectivBio Holding AG are both Biotechnology companies. Bright Minds Biosciences Inc. and VectivBio Holding AG are of similar size ($545.5M and $534.7M). Across the 9 metrics below, Bright Minds Biosciences Inc. leads on 7 and VectivBio Holding AG on 2.

Valuation

Metric DRUG VECT Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.27 3.94 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (4.05%) (27.42%) (33.15%)
Free cash flow yield (3.52%) (21.00%) (25.50%)

Profitability

Metric DRUG VECT Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (13.64%) (147.18%) (56.36%)
Return on assets (13.52%) (111.86%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DRUG VECT Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (164.58%) 34.37% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric DRUG VECT Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 121.98 9.14 4.72
Net debt to EBITDA 5.98 2.63 0.96

Dividend

Metric DRUG VECT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DRUG VECT Biotechnology median
Market cap 534.73m 545.50m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack